Scienjoy Holding Corp quarterly report, Q3 FY2019

Business context and reporting period

Entity mismatch: The supplied filing is Wealthbridge Acquisition Limited’s Form 10-Q, not a filing for Scienjoy Holding Corp. It covers the quarter and nine months ended September 30, 2019, and was filed November 14, 2019.

Wealthbridge is a British Virgin Islands blank-check company formed to pursue a business combination, with an intended focus on businesses in or around China’s air transportation and aviation industry. It reported no operating revenue and had not completed a business combination by September 30, 2019.

Financial results and position

  • Third-quarter results: Net income was $109,516, compared with a net loss of $32,311 in Q3 2018. Operating costs were $188,472; trust-account interest income was $312,316, partly offset by a $14,328 unrealized investment loss. Reported basic and diluted loss per share was $0.06, after allocating trust earnings to redeemable shares.
  • Nine-month results: Net income was $267,638 versus a $40,616 net loss for the comparable 2018 period. Operating costs were $578,536; trust-account interest income was $838,498 and unrealized gains were $7,676. Reported basic and diluted loss per share was $0.21.
  • Cash flow: Cash used in operating activities was $558,149 for the first nine months of 2019. Financing activities provided $58.2 million, principally from the IPO and private placements; $57.5 million was invested in the trust account. Cash outside the trust account rose to $169,130 from $52,937 at year-end 2018.
  • Assets and liquidity: Total assets were $58.5 million, including $58.35 million in trust-account securities, substantially U.S. Treasury bills. Current assets were $194,972. The filing says outside-trust cash is intended to fund target identification, diligence and transaction costs.
  • Liabilities and equity: Total liabilities were $2.52 million, including a $465,641 related-party promissory note and $2.01 million in deferred underwriting fees payable upon a business combination. Another $51.02 million was presented as ordinary shares subject to possible redemption, outside shareholders’ equity. Shareholders’ equity was $5.00 million.
  • Margins: Operating and gross margins are not meaningful because the company had no operating revenue.

Material changes versus the prior comparable period

The company completed its IPO and over-allotment in February 2019, raising $57.5 million for the trust account, alongside private placements. Consequently, 2019 results include substantial trust investment income and the balance sheet includes trust securities and redeemable shares; 2018 results reflect formation and operating costs only. Operating costs increased to $188,472 in Q3 from $32,311, and to $578,536 for the nine months from $40,616.

Outlook, risks and notable items

  • Wealthbridge had until February 8, 2020 to complete a business combination, with up to three optional three-month extensions. Each extension required a $575,000 trust deposit by the sponsor or its affiliates. Failure to complete a transaction within the applicable period would generally require redemption of public shares and liquidation.
  • Management expected continued acquisition-related costs and stated there was no assurance a business combination would be completed. It did not expect operating revenue before a transaction and did not believe additional funding was needed for pre-transaction operations, while acknowledging estimates could prove insufficient and additional financing might be required.
  • Trust funds are primarily reserved for a business combination or public-share redemptions. The filing notes that warrants and rights could expire worthless if no transaction is completed; redemption proceeds per share could be below $10 in some circumstances.
  • The company disclosed no long-term debt, lease obligations or off-balance-sheet financing arrangements. It did have a $10,000 monthly sponsor administrative-services fee and related-party financing arrangements.
  • Management reported disclosure controls and procedures were effective and no material changes in internal control during the quarter. No legal proceedings or material changes to previously disclosed risk factors were reported.

Important facts for investors to verify

  • Confirm the issuer: this document is for Wealthbridge Acquisition Limited, not Scienjoy Holding Corp.
  • Check the business-combination status, any extensions or later developments after the September 30, 2019 reporting date.
  • Review trust-account balances, redemption terms, extension funding requirements and the February 8, 2020 deadline.
  • Verify related-party note balances, accrued sponsor fees and the deferred underwriting fee payable upon a transaction.
  • Reconcile the reported net income with the filing’s loss-per-share calculation, which excludes earnings attributable to shares subject to possible redemption.